Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Moodys
Merck
Medtronic
Teva
Cipla
Boehringer Ingelheim
Citi
UBS

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201211

« Back to Dashboard

NDA 201211 describes BROMFENAC SODIUM, which is a drug marketed by Amring Pharms, Apotex Inc, Coastal Pharms, Hi-tech Pharmacal, and Paddock Llc, and is included in six NDAs. It is available from one supplier. Additional details are available on the BROMFENAC SODIUM profile page.

The generic ingredient in BROMFENAC SODIUM is bromfenac sodium. Four suppliers are listed for this compound. Additional details are available on the bromfenac sodium profile page.
Summary for 201211
Tradename:BROMFENAC SODIUM
Applicant:Coastal Pharms
Ingredient:bromfenac sodium
Patents:0
Therapeutic Class:Ophthalmic Agents

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrengthEQ 0.09% ACID
Approval Date:May 11, 2011TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Baxter
Queensland Health
Boehringer Ingelheim
McKesson
Accenture
Merck
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.